Cargando…
Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer
Despite of tremendous research efforts to profile prostate cancer, the genetic alterations and biological processes that correlate with disease progression remain partially elusive. In this study we show that the STAT3 small molecule inhibitor Stattic caused S-phase accumulation at low-dose levels a...
Autores principales: | Han, Zhiqiang, Wang, Xiaoli, Ma, Liang, Chen, Lijuan, Xiao, Min, Huang, Liang, Cao, Yang, Bai, Jian, Ma, Ding, Zhou, Jianfeng, Hong, Zhenya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226693/ https://www.ncbi.nlm.nih.gov/pubmed/25261365 |
Ejemplares similares
-
Tumor growth suppression by inhibiting both autophagy and STAT3 signaling in HNSCC
por: Fan, Teng-Fei, et al.
Publicado: (2015) -
Inhibition of STAT3 Reduces Astrocytoma Cell Invasion and Constitutive Activation of STAT3 Predicts Poor Prognosis in Human Astrocytoma
por: Liang, Qinchuan, et al.
Publicado: (2013) -
Osthole inhibits the progression of human gallbladder cancer cells through JAK/STAT3 signal pathway both in vitro and in vivo
por: Le Zou, Tian, et al.
Publicado: (2019) -
Neobaicalein Inhibits Th17 Cell Differentiation Resulting in Recovery of Th17/Treg Ratio through Blocking STAT3 Signaling Activation
por: Chen, Jian-Yu, et al.
Publicado: (2022) -
LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
por: Luo, Jie, et al.
Publicado: (2019)